Mastitis Market Research Report Information – Global Forecast till 2023

$4,450$6,250

Mastitis Market Research Report Information by Type (Human, Bovine), by Treatment (Antibiotics, Pain Relievers, Surgery, Vaccines, Others), by End-user (Hospitals and Clinics, Veterinary Centers, Others) and Region – Global Forecast till 2023

Clear
SKU: 190635 Categories: , Tag:

Description

Mastitis Market Research Report Information by Type (Human, Bovine), by Treatment (Antibiotics, Pain Relievers, Surgery, Vaccines, Others), by End-user (Hospitals and Clinics, Veterinary Centers, Others) and Region – Global Forecast till 2023
Market analysis

The mastitis market is mainly growing because of the advancements made in the field of medical sciences. The growing prevalence of this type of contagious diseases amongst human beings, especially women and animals like cow are some of the major factor influencing the global mastitis market positively. Factors driving the market development incorporate the rising instances of breast-related disease and expanding rate of pregnancy. On account of bovines, the unhygienic animal dwelling place conditions are the key driving element behind the market development making the infectious mastitis spread. Besides, the rising awareness about the mastitis conditions, its effective management, and the accessibility of the treatment is broadly encouraging market development. The global mastitis market is growing at a CAGR of 15.07% by targeting the value of USD 7,898.05 million during the forecast period (2017-2023).

Market segmentation

The global mastitis market has been divided on the basis of its treatment, type, end-user, and regional demand. Based on its type, the mastitis market is bifurcated into bovine mastitis and human mastitis. On the basis of its treatment, the mastitis market is classified into pain relievers, antibiotics, vaccines, surgery, and others. Based on its end-user, the mastitis market is segmented into clinics, hospitals, veterinary centers, and others.

Regional analysis

Geographically, the global mastitis market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Zoetis Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), Merck Co & Inc. (U.S.), Astellas Pharma Inc. (Japan), Pfizer Inc. (U.S.), Novartis AG (Switzerland), BioNumerik Pharmaceuticals Inc. (U.S.), Bayer AG (Germany), Oncothyreon Inc. (U.S.), Oncogenex (U.S.), Apthera Inc. (U.K.), and others are some of the major players in the global mastitis market.

Table of Contents

Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.4.3 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising cases of breast cancer
4.2.2 Increasing rate of pregnancy
4.2.3 Unhygienic barn conditions causing contagious mastitis in bovines
4.3 Restraints
4.3.1 Lack of awareness
4.3.2 Complications in diagnosis due to similar symptoms of breast cancer & mastitis
4.4 Opportunity
4.4.1 Entering developing economies
4.5 Macroeconomics
4.5.1 Trends in Mastitis
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 R&D & Designing
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-Sales Services
5.3 Investment Opportunities
5.4 Price Analysis
6 Global Mastitis Market, By Type
6.1 Introduction
6.2 Bovine
6.2.1 Contagious Mastitis
6.2.2 Environmental Mastitis
6.2.3 Opportunist Mastitis
6.3 Human
6.3.1 Non-Infectious Mastitis
6.3.2 Infectious Mastitis
7 Global Mastitis Market, By Treatment
7.1 Introduction
7.2 Bovine
7.2.1 Antibiotics
7.2.2 Vaccines
7.3 Human
7.3.1 Pain Relievers
7.3.2 Antibiotics
8 Global Mastitis Market, By End User
8.1 Introduction
8.2 Veterinary Centres
8.3 Hospital & Clinics
9 Global Mastitis Market, By Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 UK
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 Saudi Arabia
9.5.2 United Arab Emirates
9.5.3 Kuwait
9.5.4 Oman
9.5.5 Qatar
9.5.6 Rest of Middle East
10 Competitive Landscape
10.1 Competitive Scenario
10.1.1 Introduction
11 Company Profiles
11.1 Bayer AG
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products Offering
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategy
11.2 BioNumerik Pharmaceuticals Inc
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offered
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategy
11.3 Oncothyreon Inc
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offered
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategy
11.4 Oncogenex
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products/Services Offered
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategy
11.5 Apthera Inc.
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products/Services Offered
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.5.6 Key Strategy
11.6 Zoetis Inc
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products/Services Offered
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 Boehringer Ingelheim GmbH
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products/Services Offered
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 Merck Co. & Inc
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products/Services Offered
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategy
11.9 Astellas Pharma Inc
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products/Services Offered
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategy
11.1 Pfizer Inc.
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products/Services Offered
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategy
11.11 Novartis AG
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Products/Services Offered
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.11.6 Key Strategy
11.12 Sanofi S.A.
11.12.1 Company Overview
11.12.2 Financial Overview
11.12.3 Products/Services Offered
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.12.6 Key Strategy
11.13 F. Hoffmann-La Roche AG
11.13.1 Company Overview
11.13.2 Financial Overview
11.13.3 Products/Services Offered
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.13.6 Key Strategy
12 Appendix
12.1 Discussion Blue Print
12.2 References

Additional information

Publisher

Geography Covered

Date Published

Pages

Format